A Case Report | Open Access
Volume 2024 - 3 | Article ID 252 | http://dx.doi.org/10.51521/WJCRCI.2024.32.305
Academic Editor: John Bose
*aDr.
Fadi Alhussein, #bDr. AMER MOHAMMAD SUBHI ALMAFALANI
*General
Surgeon Specialist Oman, North Albatena, Shinas, Email: wwwfady2000@gmail.com
#General surgeon specialist, Oman, Ibra,
Email: ameralmefalany@gmail.com
Corresponding
Author: Dr. Fadi Alhussein,
General Surgeon Specialist, Oman, North Albatena, Shinas
Citation: Dr. Fadi Alhussein, Dr. AMER MOHAMMAD
SUBHI ALMAFALANI (2024) Basosequamous Carcinoma, and its Epidemiology,
Histopathologic Features, Treatment Methods: A Case Report. World J Case Rep
Clin Imag. 2024 November; 3(2)1-5.
Copyrights: © 2024, Dr. Fadi Alhussein, Dr. AMER
MOHAMMAD SUBHI ALMAFALANI. This article is licensed under the Creative Commons
Attribution-Non Commercial-4.0-International-License-(CCBY-NC)
(https://worldjournalofcasereports.org/blogpage/copyright-policy). Usage and
distribution for commercial purposes require written permission.
ABSTRACT
The aim of publishing this case is to
highlighting on malignant skin tumor basosequamous carcinoma BSC and try to
diagnose this disease early. Because it has highly recurrence rate and it may
sometimes causes metastases. But fortunately, it is rare.
It is important to diagnose the disease
early with the aim of reduce the morbidity rate associated with recurrence and the
mortality rate associated with metastases from. Biopsy is the gold standard for
diagnosing. Therefore, it is recommended if the skin lesions are not clinically
diagnosed, to perform a biopsy before excision, or in cases of recurrent after
the first excision. In my case, the patient presented with history of excision a
skin lesion on the occipital of the scalp with multi recurrence. And when I
performed a biopsy, and the result was basosquamous carcinoma, skin cancer.
Basosquamous carcinoma is an uncommon,
aggressive malignancy for which current literature has little consensus and is
seen by some as a distinct pathology to both BCC and SCC. However, there is
long-standing discord over where BSC falls in the non-melanoma skin cancer
spectrum, and current consensus leans towards BSC representing a subtype of
BCC. Early diagnosis and identification are key to optimal clinical outcome,
given the reported aggressive nature of the disease and high risk of recurrence
and metastasis.
Keywords: Basosquamous Carcinoma, Skin Cancer, Biopsy
.png)
.jpg)
.gif)
.jpg)
